Technetium-99m-N,N-ethylenedicysteine and Tc-99m DMSA scintigraphy in the evaluation of renal parenchymal abnormalities in children

Annals of Nuclear Medicine

Volumn 17, Issue 3, 2003, Pages 219-225

  Kibar, Mustafa ^a   Yapar, Zeynep ^a   Noyan, Aytul ^a   Anarat, Ali ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Differential renal function; Technetium 99m dimercaptosuccinic acid; Technetium 99m N,N ethylenedicysteine

Indexed keywords

CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N,N ETHYLENEDICYSTEINE TECHNETIUM TC 99M; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ETHYLENEDICYSTEINE; TECHNETIUM TC 99M-ETHYLENEDICYSTEINE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; HUMAN; INFANT; KIDNEY; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY PARENCHYMA; KIDNEY SCAR; KIDNEY SCINTISCANNING; MALE; METHODOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

EID: 0037931361     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02990025     Document Type: Article

References (34)

1. Treves ST, Majd M, Kuruc A, Packard AB, Harmon W. Kidneys. In: Treves ST (ed), Pediatric Nuclear Medicine. New York; Springer Verlag, 1995: 339-399.
2. Convay JJ. The role of scintigraphy in urinary tract infection. Semin Nucl Med 1988; 18: 308-319.
3. Tamgaç F, Moretti JL, Rocchisani JM, Baillet G, Weinmann P. Tc-99m MAG3 and Tc-99m DMSA in the detection and assessment of pyelonephritis. J Nucl Biol Med 1993; 37: 62-64.
4. Merrick MV, Uttley WS, Wild SR. The detection of pyelonephritic scarring in children by radioisotope imaging. Br J Radiol 1980; 53: 544-556.
5. Goldraich NP, Ramos OL, Goldraich IH. Urography versus DMSA scan in children with vesicoureteric reflux. Pediatric Nephrol 1989; 3: 1-5.
6. Willis KW, Martinez DA, Hedley WE, Uttley WS. Renal localization of Tc-99m stannous glucoheptonate and Tc-99m dimercaptosuccinate in the rat by frozen section autoradiography: the efficiency and resolution of technetium-99m. Radiat Res 1977; 69: 475-488.
7. Erlander D, Weber PM, dosRemedios LV. Renal cortical imaging in 35 patients: superior quality with Tc-99m DMSA. J Nucl Med 1974; 15: 743-749.
8. Arnold RW, Subramanian G, McAfee JG. Comparison of Tc-99m complexes for renal imaging. J Nucl Med 1975; 16: 357-367.
9. Smith T, Veall N, Altman G. Dosimetry of renal radiopharmaceuticals: the importance of bladder radioactivity and a simple aid for its estimation. Br J Radiol 1981; 54: 961-964.
10. Johansson L, Mattsson S, Nosslin B. Effective dose equivalent from radiopharmaceuticals. Eur J Nucl Med 1984; 9: 485-489.
11. Verboven M, Ham HR, Josephson S. How inaccurate are the 5 h measurements? Nucl Med Commun 1987; 8: 45-47.
12. Van Nerom C, Waer M, Claeys C, De Roo MJ. Clinical evaluation of Tc-99m-L,L-EC as an alternative for Tc-99m-MAG3 in renal transplant patients. In: Schmidt HAE, Hofer R (eds), Nuclear medicine in research and practice. Stuttgart, Germany; Schattauer, 1992: 560-563.
13. Verbruggen AM, Nosco LD, Van Nerom C, Bormans GM, Adriaens P, De Roo MJ. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med 1992; 33: 551-557.
14. Van Nerom C, Bormans GM, De Roo M, Verbruggen AM. First experience in healthy volunteers with technetium-99m-L,L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med 1993; 20 (9): 738-746.
15. Ozker K, Kabasakal L, Liu Y, Hellman RS, Isitman A, Krasnow AZ, et al. Evaluation of Tc-99m-bicisate as a renal imaging agent. Nucl Med Commun 1997; 18: 771-775.
16. Kabasakal L, Turoglu HT, Onsel Ç, et al. Comparative continuous infusion renal clearance of Tc-99m-EC, Tc-99m-MAG3 and I-131-OIH in renal disorders. J Nucl Med 1995; 36: 224-228.
17. Ugur O, Caner B, Cekirge S, Balkanci F, Ergun EL, Kostakoglu L, et al. The diagnosis of renovascular hypertension with technetium-99m-ethylenedicysteine captopril scintigraphy. Invest Radiol 1996; 31: 378-381.
18. Kibar M, Noyan A, Anarat A. Tc-99m-N,N-ethylenedicysteine scintigraphy in children with various renal disorder: a comparative study with Tc-99m-MAG3. Nucl Med Commun 1997; 18: 44-52.
19. Kabasakal L, Erdil TY, Ayaz M, et al. Evaluation of Tc-99m-EC in anuric hemodialysis patients. Eur J Nucl Med 1996; 23: 1187.
20. Kabasakal L. Technetium-99m ethylenedicysteine: a new renal tubular function agent. Eur J Nucl Med 2000; 27: 351-357.
21. Kabasakal L, Atay S, Vural VA, et al. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio. J Nucl Med 1995; 36: 1398-1403.
22. Eshima D, Eshima L, Hansen L, Lipowska M, Marzilli LG, Taylor A. Effect of protein binding on renal extraction of I-131 OIH and Tc-99m-labelled tubular agents. J Nucl Med 2000; 41: 2077-2082.
23. Stoffel M, Jamar F, Van Nerom C, Verbruggen A, Besse T, Squifflet JP, et al. Technetium-99m-L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow. Eur J Nucl Med 1996; 23: 365-370.
24. Kabasakal L, Yapar AF, Ozker K, Alkan E, Atay S, Ozcelik N, et al. Simplified technetium-99m-EC clearance in adults from a single plasma sample. J Nucl Med 1997; 38: 1784-1786.
25. Kabasakal L, Halac M, Yapar AF, Alkan E, Kanmaz B, Onsel C, et al. Prospective validation of single plasma sample Tc-99m ethylenedicysteine clearance in adults. J Nucl Med 1999; 40: 429-431.
26. Itturalde MP. Dictionary and Handbook of Nuclear Medicine and Clinical Imaging. Boston; CRC Press, 1990: 433.
27. Ozker K, Onsel C, Kabasakal L, Sayman HB, Uslu I, Bozluolcay S, et al. Technetium-99m-N,N-ethylenedicysteine - A comparative study of renal scintigraphy with technetium-99m-MAG3 and Iodine-131-OIH in patients with obstructive renal disease. J Nucl Med 1994; 35: 840-845.
28. Gordon I, Colarinha P, Fettich J, Fischer S, Frökier J, Hahn K, et al. Guidelines for standard and diuretic renogram in children. http://www.eanm.org/scientific_info/guide_pdf/ gl_reno_en.pdf
29. Piepsz A. Radionuclide studies in paediatric nephro-urology. Eur J Radiol 2002; 43 (2): 146-153.
30. Gupta NK, Bomanji JB, Waddington W, Lui D, Costa DC, Verbruggen AM, et al. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders. Eur J Nucl Med 1995; 22: 617-624.
31. Whitear P, Shaw P, Gordon I. Comparison of Tc-99m DMSA scans and in intravenous urography in children. Br J Radiol 1990; 63: 438.
32. Gordon I, Anderson PJ, Lythgoe MF, Orton M. Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect? J Nucl Med 1992; 33: 2090-2093.
33. Bair HJ, Becker W, Schott G, Kuhn RH, Wolf G. Is there still a need for Tc-99m DMSA renal imaging? Clin Nucl Med 1995; 20: 18-21.
34. Caglar M, Yaris N, Akyuz C. The utility of Tc-99m DMSA and Tc-99mEC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity. Nucl Med Commun 2001; 22 (12): 1325-1332.